HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
4317studies shown
Showing 2,929-2,940 of 4,317
Drug study icon
RecruitingNCT06374277

Pharmacy-led medication support after hospital discharge

About this title

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

Read the official source — NCT06374277
Official study title

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations

In Memphis
Anxiety, DepressionPlacebo comparisonAges 18+
Countries
United States
Sponsor
University of Tennessee
Drug study icon
RecruitingNCT07029581

ACP-204 for psychosis in Lewy body dementia

About this title

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Read the official source — NCT07029581
Official study title

A Double-Blind, Placebo-Controlled, Phase 2, Efficacy and Safety Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)

Multiple locations, including Irvine
SchizophreniaMedication studyAges 55–84
Countries
United States, France, Bulgaria, + 3 others
Sponsor
ACADIA Pharmaceuticals Inc.
Drug study icon
RecruitingNCT06559306

Seltorexant or placebo added to antidepressants for depression with insomnia

About this title

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Read the official source — NCT06559306
Official study title

A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-(Milligram) mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms

Multiple locations, including Tucson
DepressionMedication studyAges 18–74
Countries
United States, Argentina, Brazil, + 13 others
Sponsor
Janssen Research & Development, LLC
Drug study icon
RecruitingNCT07095465

Long-term ACP-204 treatment for psychosis in Lewy body dementia

About this title

Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

Read the official source — NCT07095465
Official study title

52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)

Multiple locations, including Irvine
SchizophreniaMedication studyAges 55–84
Countries
United States, France, Bulgaria, + 3 others
Sponsor
ACADIA Pharmaceuticals Inc.
Behavioral study icon
RecruitingACTRN12613000271707

Phase I of a Mindfulness-Based Stress Reduction intervention for Head and Neck Cancer patients receiving treatment of curative intent.

Official study title

A phase I pilot trial with no comparison group to assess the feasibility and acceptability of an adapted Mindfulness-Based Stress Reduction program for Head and Neck Cancer patients undergoing radiotherapy with curative intent.

In East Melbourne
Mental healthInterventional studyAges 18+
Countries
Australia
Sponsor
Beyond Blue Limited (beyondblue)
Behavioral study icon
RecruitingNCT06685003

Digital training for addiction professionals supporting families affected by opioid use

About this title

Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families

Read the official source — NCT06685003
Official study title

Phase II: Scalable Digital Delivery of Evidence-based Training for Addiction Professionals to Maximize Treatment Admission and Retention Rates of Opioid Use Disorder in Affected Families

In New York
AddictionBehavioural studyAges 18+
Countries
United States
Sponsor
We The Village, Inc.
Behavioral study icon
RecruitingNCT05855668

Cognitive and emotional profiles in people receiving CBT for alcohol or cannabis use

About this title

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

Read the official source — NCT05855668
Official study title

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

In Toronto
AddictionBehavioural studyAges 18+
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.